News Detail
New Delhi, 15 June 2024: The National Pharmaceutical Pricing Authority (NPPA) has invoked the Para 3 of the Drugs (Prices Control) Order, 2013, and directed Mumbai-based Macleods Pharmaceuticals to supply anti-tuberculosis drug rifampicin 150 mg and 450 mg capsules to the c......
View Details
Source : Pharmabiz
NPPA
Para 3
Drugs (Prices Control) Order
Macleods Pharmaceuticals
anti-tuberculosis drug
rifampicin
Central Medical Services Society
CMSS
DPCO
2013
API
bulk drug
National Tuberculosis Elimination Programme
NTEP
Lok Sabha
Related News
- DCA Seizes Overpriced, misleading claim Medicine (26-06-2024)
- Inquiry demanded at Maharashtra Assembly on export nod for over 200 pharma companies without stability testing (26-06-2024)
- Spurious drug factory busted in Gandhinagar (26-06-2024)
- Gang involved in illegal drug trade busted; 11 arrested (26-06-2024)
- 90% of healthcare companies get a 'B+' on cybersecurity with medical devices (26-06-2024)
- US lawmakers questions FDAs drug inspection programme in India and China (25-06-2024)
- Two arrested with 36,000 bottles of banned cough syrup in Siliguri (25-06-2024)
- DoP further expands list of special invitees into committee constituted to reform pricing framework (25-06-2024)
- India key market for APIs, but patients forced to cough up crores to buy orphan drugs (25-06-2024)
- Govt considers ban on two antibiotics for poultry and animal feed supplements (25-06-2024)